A detailed history of Strategic Blueprint, LLC transactions in Danaher Corp stock. As of the latest transaction made, Strategic Blueprint, LLC holds 9,136 shares of DHR stock, worth $2.19 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
9,136
Previous 8,804 3.77%
Holding current value
$2.19 Million
Previous $2.04 Million 12.03%
% of portfolio
0.17%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$224.58 - $256.19 $74,560 - $85,055
332 Added 3.77%
9,136 $2.28 Million
Q4 2023

Jan 25, 2024

BUY
$185.1 - $233.13 $66,265 - $83,460
358 Added 4.24%
8,804 $2.04 Million
Q3 2023

Oct 18, 2023

BUY
$233.08 - $265.59 $111,878 - $127,483
480 Added 6.03%
8,446 $2.1 Million
Q2 2023

Oct 18, 2023

BUY
$224.99 - $256.14 $44,548 - $50,715
198 Added 2.55%
7,966 $1.91 Million
Q1 2023

Apr 28, 2023

BUY
$239.75 - $277.0 $62,574 - $72,297
261 Added 3.48%
7,768 $1.96 Million
Q4 2022

Jan 26, 2023

BUY
$241.42 - $282.29 $15,692 - $18,348
65 Added 0.87%
7,507 $0
Q3 2022

Nov 08, 2022

BUY
$247.06 - $1507.4 $48,423 - $295,450
196 Added 2.7%
7,442 $1.92 Million
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $309,191 - $390,756
1,304 Added 21.95%
7,246 $1.84 Million
Q1 2022

Aug 12, 2022

BUY
$257.27 - $315.76 $1.34 Million - $1.65 Million
5,216 Added 718.46%
5,942 $1.74 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $212,050 - $238,861
726 New
726 $238,000
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $54,714 - $66,818
-201 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$225.08 - $271.69 $45,241 - $54,609
201 New
201 $53,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $175B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Strategic Blueprint, LLC Portfolio

Follow Strategic Blueprint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.